McCormick & Company, Inc. — FRENCH’S, HORSERADISH MUSTARD
by McCormick & Company, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
MRT 176 Panel Safety Assessment
Clinical Narrative
This product contains two MRT-tested substances: Mustard and Garlic. Furthermore, the presence of ‘Spices’ and ‘Natural Flavor’ introduces unknown variables as they may contain hidden MRT triggers. Because of these unidentified components, the product requires practitioner guidance or individual testing and is not compatible with Phase 1 elimination.
Flagged Ingredient Mapping
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| mustard seed | Mustard | DIRECT_MATCH |
| garlic powder | Garlic | DIRECT_MATCH |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped: spices, natural flavor
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Mustard is tested on the MRT panel and recognized as a major allergen in the EU. Found in condiments, dressings, marinades, and often hidden in spice blends and processed meats.
Garlic is an MRT-tested substance found in seasoning blends, sauces, and many processed foods. Often listed as "garlic powder," "dehydrated garlic," or hidden in "spices" or "natural flavors."
What This Means For Your Diet
With 2 identified triggers, this product falls into the moderate risk category. It may be suitable for Phase 2 reintroduction under practitioner guidance, depending on your individual MRT results.
If the specific triggers identified in this product scored Green on your personal MRT panel, your CLT may approve it for controlled reintroduction. If they scored Yellow or Red, this product should be avoided until cleared.
Full Ingredient List
mustard seed, garlic powder
More from McCormick & Company, Inc.
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners